{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:21Z","timestamp":1787504061104,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302938"],"award-info":[{"award-number":["82302938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11397-w","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:00:19Z","timestamp":1752613219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening and validation of key genes involved in castration-resistant prostate cancer based on transcriptomics sequencing"],"prefix":"10.1038","volume":"15","author":[{"given":"Guangquan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farra Aidah","family":"Jumuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"1","key":"11397_CR1","first-page":"12","volume":"74","author":"R Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J Clin 74, 12\u201349 (2024). https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"Cancer Stat. 2024 CA: cancer J. Clin."},{"issue":"2","key":"11397_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00345-011-0801-1","volume":"30","author":"K Hemminki","year":"2012","unstructured":"Hemminki, K. Familial risk and familial survival in prostate cancer. World J Urol 30, 143\u2013148 (2012). https:\/\/doi.org\/10.1007\/s00345-011-0801-1","journal-title":"World J. Urol."},{"issue":"1","key":"11397_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J Clin 72, 7\u201333 (2022). https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J. Clin."},{"key":"11397_CR4","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1038\/s41467-022-32701-6","volume":"13","author":"TC Westbrook","year":"2022","unstructured":"Westbrook, T. C. et al. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nat Commun 13, 5345 (2022). https:\/\/doi.org\/10.1038\/s41467-022-32701-6","journal-title":"Nat. Commun."},{"issue":"11","key":"11397_CR5","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","volume":"15","author":"J Cuzick","year":"2014","unstructured":"Cuzick, J. et al. Prevention and early detection of prostate cancer. Lancet Oncol 15, e484\u2013492 (2014). https:\/\/doi.org\/10.1016\/s1470-2045(14)70211-6","journal-title":"Lancet Oncol."},{"issue":"1","key":"11397_CR6","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/s41467-018-04724-5","volume":"9","author":"E Berglund","year":"2018","unstructured":"Berglund, E. et al. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nat Commun 9, 2419 (2018). https:\/\/doi.org\/10.1038\/s41467-018-04724-5","journal-title":"Nat. Commun."},{"issue":"4","key":"11397_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.bjc.6602034","volume":"91","author":"I Rehman","year":"2004","unstructured":"Rehman, I. et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 91, 739\u2013744 (2004). https:\/\/doi.org\/10.1038\/sj.bjc.6602034","journal-title":"Br. J. Cancer"},{"key":"11397_CR8","doi-asserted-by":"crossref","unstructured":"Cheng, S. et al. Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. NPJ Precis Oncol 8, 171 (2024). https:\/\/doi.org\/10.1038\/s41698-024-00667-x","DOI":"10.1038\/s41698-024-00667-x"},{"key":"11397_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan, Q., Shai, O., Lee, L. J., Frey, B. J. & Blencowe, B. J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40, 1413\u20131415 (2008). https:\/\/doi.org\/10.1038\/ng.259","journal-title":"Nat. Genet."},{"key":"11397_CR10","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1101\/gad.1973010","volume":"24","author":"CJ David","year":"2010","unstructured":"David, C. J. & Manley, J. L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24, 2343\u20132364 (2010). https:\/\/doi.org\/10.1101\/gad.1973010","journal-title":"Genes Dev."},{"key":"11397_CR11","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-04-1910","volume":"64","author":"JP Venables","year":"2004","unstructured":"Venables, J. P. Aberrant and alternative splicing in cancer. Cancer Res 64, 7647\u20137654 (2004). https:\/\/doi.org\/10.1158\/0008-5472.Can-04-1910","journal-title":"Cancer Res."},{"key":"11397_CR12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1038\/s41467-020-15815-7","volume":"11","author":"D Zhang","year":"2020","unstructured":"Zhang, D. et al. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nat Commun 11, 2089 (2020). https:\/\/doi.org\/10.1038\/s41467-020-15815-7","journal-title":"Nat. Commun."},{"key":"11397_CR13","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1158\/0008-5472.CAN-11-3892","volume":"72","author":"R Hu","year":"2012","unstructured":"Hu, R. et al. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res 72, 3457\u20133462 (2012). https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3892","journal-title":"Cancer Res."},{"key":"11397_CR14","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1158\/1078-0432.CCR-13-1863","volume":"20","author":"Z Yu","year":"2014","unstructured":"Yu, Z. et al. Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer. Clin Cancer Res 20, 1590\u20131600 (2014). https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-1863","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"11397_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eururo.2016.04.028","volume":"71","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. Eur Urol 71, 68\u201378 (2017). https:\/\/doi.org\/10.1016\/j.eururo.2016.04.028","journal-title":"Eur. Urol."},{"key":"11397_CR16","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1158\/1078-0432.CCR-15-0157","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clin Cancer Res 21, 4698\u20134708 (2015). https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0157","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"11397_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.08.011","volume":"35","author":"AR Lee","year":"2018","unstructured":"Lee, A. R., Gan, Y., Tang, Y. & Dong, X. A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network. EBioMedicine 35, 167\u2013177 (2018). https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.011","journal-title":"EBioMedicine"},{"key":"11397_CR18","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.ebiom.2019.11.008","volume":"51","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas, J. M. et al. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine 51, 102547 (2020). https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008","journal-title":"EBioMedicine"},{"key":"11397_CR19","doi-asserted-by":"publisher","first-page":"15921","DOI":"10.1038\/ncomms15921","volume":"8","author":"BD Wang","year":"2017","unstructured":"Wang, B. D. et al. Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun 8, 15921 (2017). https:\/\/doi.org\/10.1038\/ncomms15921","journal-title":"Nat. Commun."},{"issue":"1","key":"11397_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-biochem-080111-092106","volume":"84","author":"G Singh","year":"2015","unstructured":"Singh, G., Pratt, G., Yeo, G. W. & Moore, M. J. The Clothes Make the mRNA: Past and Present Trends in mRNP Fashion. Annu Rev Biochem 84, 325\u2013354 (2015). https:\/\/doi.org\/10.1146\/annurev-biochem-080111-092106","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"11397_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12094-022-02933-5","volume":"25","author":"R Feng","year":"2023","unstructured":"Feng, R. et al. NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathway. Clin Transl Oncol 25, 243\u2013255 (2023). https:\/\/doi.org\/10.1007\/s12094-022-02933-5","journal-title":"Clin. Transl Oncol."},{"issue":"4","key":"11397_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2015.109","volume":"35","author":"P Adamo","year":"2016","unstructured":"Adamo, P. & Ladomery, M. R. The oncogene ERG: a key factor in prostate cancer. Oncogene 35, 403\u2013414 (2016). https:\/\/doi.org\/10.1038\/onc.2015.109","journal-title":"Oncogene"},{"issue":"23","key":"11397_CR23","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci U S A 116, 11428\u201311436 (2019). https:\/\/doi.org\/10.1073\/pnas.1902651116","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"11397_CR24","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/ijms23063042","volume":"23","author":"R Ahmed","year":"2022","unstructured":"Ahmed, R. et al. Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues. Int J Mol Sci 23 (2022). https:\/\/doi.org\/10.3390\/ijms23063042","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"11397_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/ijms22031422","volume":"22","author":"S Supplitt","year":"2021","unstructured":"Supplitt, S., Karpinski, P., Sasiadek, M. & Laczmanska, I. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. Int J Mol Sci 22 (2021). https:\/\/doi.org\/10.3390\/ijms22031422","journal-title":"Int. J. Mol. Sci."},{"key":"11397_CR26","first-page":"d1356","volume":"7","author":"CW Heizmann","year":"2002","unstructured":"Heizmann, C. W., Fritz, G. & Sch\u00e4fer, B. W. S100 proteins: structure, functions and pathology. Front Biosci 7, d1356\u20131368 (2002). https:\/\/doi.org\/10.2741\/a846","journal-title":"Front. Biosci."},{"issue":"2","key":"11397_CR27","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.1038\/cddis.2014.31","volume":"5","author":"NE Buckley","year":"2014","unstructured":"Buckley, N. E., D'Costa, Z., Kaminska, M. & Mullan, P. B. S100A2 is a BRCA1\/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. Cell Death Dis 5, e1070 (2014). https:\/\/doi.org\/10.1038\/cddis.2014.31","journal-title":"Cell. Death Dis."},{"issue":"6","key":"11397_CR28","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1111\/jcmm.16343","volume":"25","author":"H Zhuang","year":"2021","unstructured":"Zhuang, H. et al. Prognostic values and immune suppression of the S100A family in pancreatic cancer. J Cell Mol Med 25, 3006\u20133018 (2021). https:\/\/doi.org\/10.1111\/jcmm.16343","journal-title":"J. Cell. Mol. Med."},{"key":"11397_CR29","doi-asserted-by":"publisher","first-page":"216709","DOI":"10.1016\/j.canlet.2024.216709","volume":"587","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE\/NF-kB\/VEGF-D pathway. Cancer Lett 587, 216709 (2024). https:\/\/doi.org\/10.1016\/j.canlet.2024.216709","journal-title":"Cancer Lett."},{"issue":"3","key":"11397_CR30","doi-asserted-by":"publisher","first-page":"167633","DOI":"10.1016\/j.bbadis.2024.167633","volume":"1871","author":"X Xu","year":"2025","unstructured":"Xu, X. et al. FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination. Biochim Biophys Acta Mol Basis Dis 1871, 167633 (2025).\u00a0https:\/\/doi.org\/10.1016\/j.bbadis.2024.167633","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"13","key":"11397_CR31","doi-asserted-by":"publisher","first-page":"111404","DOI":"10.1016\/j.celrep.2022.111404","volume":"40","author":"M Del Giudice","year":"2022","unstructured":"Del Giudice, M. et al. FOXA1 regulates alternative splicing in prostate cancer. Cell Rep 40, 111404 (2022). https:\/\/doi.org\/10.1016\/j.celrep.2022.111404","journal-title":"Cell. Rep."},{"key":"11397_CR32","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo, R. et al. The role of alternative splicing in cancer: From oncogenesis to drug resistance. Drug Resist Updat 53, 100728 (2020). https:\/\/doi.org\/10.1016\/j.drup.2020.100728","journal-title":"Drug Resist. Updat"},{"issue":"9","key":"11397_CR33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams, H. et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine 2, 1133\u20131144 (2015). https:\/\/doi.org\/10.1016\/j.ebiom.2015.07.017","journal-title":"EBioMedicine"},{"issue":"1\u20132","key":"11397_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2003.08.009","volume":"210","author":"H Qi","year":"2003","unstructured":"Qi, H., Grenier, J., Fournier, A. & Labrie, C. Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Mol Cell Endocrinol 210, 51\u201362 (2003). https:\/\/doi.org\/10.1016\/j.mce.2003.08.009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"44","key":"11397_CR35","doi-asserted-by":"publisher","first-page":"45753","DOI":"10.1074\/jbc.M407858200","volume":"279","author":"PM Snyder","year":"2004","unstructured":"Snyder, P. M., Olson, D. R., Kabra, R., Zhou, R. & Steines, J. C. cAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+) channel through convergent phosphorylation of Nedd4-2. J Biol Chem 279, 45753\u201345758 (2004). https:\/\/doi.org\/10.1074\/jbc.M407858200","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11397-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:24:32Z","timestamp":1757244272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11397-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Animal Care and Use Committee of the Dalian Medical University approved the use of animal models in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"25648"}}